Oncology Research

Papers
(The TQCC of Oncology Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Retraction notice to Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184 [Oncology Research 26(2) (2018) 297-305]23
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP119
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells19
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer19
Progress on diagnostic and prognostic markers of pancreatic cancer18
miR-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in Breast Cancer16
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes15
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells14
Konjac glucomannan enhances 5-FU-induced cytotoxicity of hepatocellular carcinoma cells via TLR4/PERK/CHOP signaling to induce endoplasmic reticulum stress13
Erratum: Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells13
ScRNA-seq reveals the correlation between M2 phenotype of tumor-associated macrophages and lymph node metastasis of breast cancer12
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape12
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance12
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer11
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study10
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells10
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma10
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials10
Galectins dysregulation: A way for cancer cells to invade and pervade10
Tumor neoantigens: Novel strategies for application of cancer immunotherapy10
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling10
A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells8
Erratum: Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells8
Retraction notice to High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells [Oncology Research 27(9) (2019) 10258
MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer [Oncology Research 26(5) (2018) 775783]8
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities8
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis8
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma7
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells7
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations7
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission7
The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients7
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany7
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer6
LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway6
Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma6
Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as t6
Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma6
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer6
The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment6
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu閞in in patients with non-muscle invasive bladder carcinoma: A retrospective study6
0.037974119186401